Efficacy and safety of dupilumab in patients with PN with or without a history of atopic comorbidities
Efficacy and safety of dupilumab in patients with PN with or without a history of atopic comorbidities
Bekijk meer
StartpaginaArtikelen
Voor zorgverleners
Beyfortus®▼(nirsevimab): effectiveness and public health impact in the real world
Beyfortus
Bekijk meer
Atopisch Eczeem bij kinderen
Atopisch Eczeem bij kinderen
Bekijk meer
Verborgen ziektelast bij EoE eerder herkennen
Verborgen ziektelast bij EoE eerder herkennen
Bekijk meer
Mechanism of Disease
Complex immune dysregulation can lead to autoimmunity and inflammation1-6
Bekijk meer
Living with ITP
Patients reported significant quality of life (QoL) challenges related to their ITP1
Bekijk meer
What is Immune Thrombocytopenia (ITP)?
Low platelet counts are one facet of ITP, but when we look at it from another angle, we see the multiple dimensions of ITP. ITP is a condition of complex immune dysregulation that reduces platelet counts—causing bleeding, bruising, fatigue, and other health-related quality-of-life (HRQoL) issues—while increasing inflammation and the risk of thromboembolic events (TEs).1-5
Bekijk meer
Assessing fatigue in ITP patients
For ITP patients, several scales are available to measure and track fatigue and its impact on quality of life. These tools can help patients and healthcare providers gauge symptoms and adjust their ITP treatment accordingly.1-4
Bekijk meer
FLUNITY-HD Study Demonstrated the Superior Protection Beyond Flu of High-Dose Flu Vaccine vs Standard-Dose Flu Vaccine*
FLUNITY-HD is the largest individually randomised influenza vaccine effectiveness study, with nearly half a million older adults across multiple seasons.1
Bekijk meer